These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 18692403

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of the peptidoglycan of vancomycin-susceptible Enterococcus faecium.
    Patti GJ, Kim SJ, Schaefer J.
    Biochemistry; 2008 Aug 12; 47(32):8378-85. PubMed ID: 18642854
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin and oritavancin have different modes of action in Enterococcus faecium.
    Patti GJ, Kim SJ, Yu TY, Dietrich E, Tanaka KS, Parr TR, Far AR, Schaefer J.
    J Mol Biol; 2009 Oct 09; 392(5):1178-91. PubMed ID: 19576226
    [Abstract] [Full Text] [Related]

  • 4. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
    Chang JD, Foster EE, Yang H, Kim SJ.
    Biochemistry; 2017 Jan 31; 56(4):612-622. PubMed ID: 28040891
    [Abstract] [Full Text] [Related]

  • 5. Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VanB type.
    Billot-Klein D, Shlaes D, Bryant D, Bell D, van Heijenoort J, Gutmann L.
    Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):711-5. PubMed ID: 8611145
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry.
    Chang JD, Foster EE, Thadani AN, Ramirez AJ, Kim SJ.
    J Bacteriol; 2017 Aug 01; 199(15):. PubMed ID: 28507244
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalis.
    Chang JD, Foster EE, Wallace AG, Kim SJ.
    Sci Rep; 2017 Apr 13; 7():46500. PubMed ID: 28406232
    [Abstract] [Full Text] [Related]

  • 10. Fluorescence assay to predict activity of the glycopeptide antibiotics.
    Vimberg V, Gazak R, Szűcs Z, Borbás A, Herczegh P, Cavanagh JP, Zieglerova L, Závora J, Adámková V, Balikova Novotna G.
    J Antibiot (Tokyo); 2019 Feb 13; 72(2):114-117. PubMed ID: 30504918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peptidoglycan composition of vancomycin-resistant Enterococcus faecium.
    de Jonge BL, Gage D, Handwerger S.
    Microb Drug Resist; 1996 Feb 13; 2(2):225-9. PubMed ID: 9158764
    [Abstract] [Full Text] [Related]

  • 13. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J, Pierce JG, James RC, Okano A, Boger DL.
    J Am Chem Soc; 2011 Sep 07; 133(35):13946-9. PubMed ID: 21823662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.
    Allen NE, Hobbs JN, Nicas TI.
    Antimicrob Agents Chemother; 1996 Oct 07; 40(10):2356-62. PubMed ID: 8891144
    [Abstract] [Full Text] [Related]

  • 17. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
    Chiosis G, Boneca IG.
    Science; 2001 Aug 24; 293(5534):1484-7. PubMed ID: 11520986
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D.
    Science; 1999 Apr 16; 284(5413):507-11. PubMed ID: 10205063
    [Abstract] [Full Text] [Related]

  • 20. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum.
    Billot-Klein D, Gutmann L, Sablé S, Guittet E, van Heijenoort J.
    J Bacteriol; 1994 Apr 16; 176(8):2398-405. PubMed ID: 8157610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.